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ABSTRACT 
Calotropis gigantea white (Asclepiadaceae) has been documented as a traditional treatment of diabetes. The aim of this study was to 
evaluate the antidiabetic activity of chloroform and ethyl acetate extracts from the flower in normal and alloxan-induced diabetic 
rats. Blood samples were obtained and blood glucose levels were analyzed employing a glucometer at different time intervals on 1st, 
4th, 8th and 12th day of the treatment with C. gigantea white extracts compare to glibenclamide (10 mg / kg). From the results, it is 
revealed that the test chloroform, and ethyl acetate extracts at a dose level 500 mg / kg, showed a significant reduction in blood sugar 
level day in a progressive manner comparable to glibenclamide. Biochemical parameters, including hemoglobin, urea, creatinine, 
serum cholesterol, low-density lipoprotein (LDL), and high-density lipoprotein (HDL) were also assessed. Treatment of diabetic rats 
with the two extracts of this plant restored the elevated biochemical parameters significantly (p<0.05) to the normal level. It also 
proves the traditional claim with regard to C. gigantea white for its anti-diabetic activity. 
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INTRODUCTION 
Diabetes is a chronic disorder in the metabolism of 
carbohydrates, proteins, and fat due to absolute or 
relative deficiency of insulin secretion with/without 
varying the degree of insulin resistance
1
. Effective blood 
glucose control is the key to preventing or reversing 
diabetic complications and improving the quality of life 
in patients with diabetes
2
. Diabetes also gives rise to 
various secondary problems such as cataracts, 
microvascular problems, and neuropathy. These 
secondary problems commonly arise due to oxidative 
stress and DNA damage caused in cells by means of free 
radical generation
3
. Management of diabetes without 
side effects is still challenging to the medical 
community. Pharmacological and clinical trials of 
medicinal plants have shown anti-diabetic effects and 
repair of β-cells of islets of Langerhans4. Many of these 
medicinal plants and herbs are a potential source of 
many drugs used in modern medicine, for example, 
quinine, opium alkaloids, atropine, cardiac glycosides 
(digitalis) and the popular hypoglycemic drug 
glucophage (metformin), derived from Galega 
officinalis
5
. A wide range of plants has been reported in 
the literature to prevent and treat diabetes.  
Calotropis gigantea white (Asclepiadaceae), commonly 
known as milkweed or swallow-worth, is found chiefly 
in temples and Wasteland throughout India
6
. The 
traditional healers suggested that, when using C. 
gigantea for medication, white flowering should be 
preferred over purple flowering. It is known for various 
medicinal properties in the traditional medicinal system 
and uses to cure a variety of diseases. It has been 
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reported as a traditional folkloric medicine for treatment 
of asthma in the Indian literature
7
. Phytochemical 
studies on Calotropis have afforded several types of 
compounds such as Cardenolide, triterpenoids, 
alkaloids, resins, anthocyanins and proteolytic enzymes 
in latex, flavonoids, tannins, sterol, saponins and cardiac 
glycosides. Flowers contain terpenes, multi fluorenol, 
and cyclisadol
8
. Hence, taking into consideration the 
traditional evaluation and reported activities, the present 
study was undertaken to test plant C. gigantea white for 
its antidiabetic activities of the extract on alloxan 
induced rats as animal model and the effect of the 
carbohydrate metabolizing enzymes and lipid, as no 
work is done in this direction and to check possible role 
of plant in antidiabetic activity.  
MATERIALS AND METHODS 
Collection and identification of plant material 
Calotropis gigantea white, flowers were collected in the 
month of February - March from the campus of Siva 
Temple, Thiruvisanallur, Thanjavur India and the plant 
was identified by Dr. N. Ramakrishnan, Associate 
Professor and Head, Department of Botany, 
Government Arts College (Autonomous), Bharathidasan 
University, Trichirappalli, Tamilnadu, India. A voucher 
specimen (GACBOT-107) was deposited in the research 
laboratory, Botany for future reference. The collected 
fresh flower materials were washed properly and dried 
in the shade. Dried plant material was subjected to 
reduction to coarse powdered and stored in airtight 
container for further use. 
Preparation of plant extract 
The flowers (500 g) of Calotropis gigantea white were 
extracted three times with 95% methanol (4 X 500 mL) 
at room temperature (30 ± 2 °C). Following filtration, 
the combined methanol extract was evaporated to 
dryness under reduced pressure to give a crude extract. 
The crude methanol extract was suspended in hot water 
(1000 mL) and that was subjected to column 
chromatography over Silica gel using with chloroform 
and ethyl acetate, and the solvent recovered by simple 
distillation. Evaporation of the solvent under reduced 
pressure gave the crude extract CHCl3 (39.0 g) and 
EtOAc (28.0 g) respectively. Each extract was dissolved 
in distilled water before its administration to the diabetic 
rats. This was prepared by dissolving 2 g of plant extract 
in 25 mL 2% Tween - 80 / distilled water and normal 
saline in a falcon tube in a hot water bath with vigorous 
shaking. The dose of each extract was calculated 
according to body weight before administration to the 
diabetic rats. 
Experimental animals 
Wistar albino rats (200-220 g) of either sex were used 
for this study and were kept in the animal house at 25 ± 
2°C with relative humidity 50-55% along with light and 
dark cycles of 12 h respectively (6-10 h light, 18-6 h 
dark). The animals were fed with Standard animal feed 
(Hindustan Lever Ltd.) and water was applied ad 
libitum. The animal experiments were carried out in 
accordance with the guidelines of Committee for the 
Purpose of Care and Supervision of Experimental 
Animals (CPCSEA) after approval from Institutional 
Animal Ethics Committee (IAEC), Bharathidasan 
University, Trichirappalli, Tamilnadu, India (Approval 
No. BDU/IAEC/2011/31/29.03.2011). 
Experimental design 
The animals were divided into six groups each 
containing six animals. 
Group-I: Served as normal control. Control rats received 
only normal saline. 
Group-II: The Second group of rats with diabetes was 
induced by intraperitoneal injection of alloxan for 2 
days. 
Group-III: Alloxan treated rats were administered the 
Glibenclamide (10 mg/ kg) and served as standard. 
Group-IV: Alloxan treated rats were administered the 
chloroform extract of Calotropis gigantea white (250 
mg / kg) 
Group-V:  Alloxan treated rats were administered the 
chloroform extract of Calotropis gigantea white (500 
mg / kg) 
Group-VI: Alloxan treated rats were administered the 
ethyl acetate extract of Calotropis gigantea white 
(250mg / kg) 
Group-VII: Alloxan treated rats were administered the 
ethyl acetate extract of Calotropis gigantea white 
(250mg / kg) 
After the treatment period all the groups of rats were 
euthanized by anesthesia using chloroform vapor and 
the rats were sacrificed by decapitation. Then the blood 
was collected in a tube for analysis. 
Acute toxicity studies 
The resulting extracts were subjected to acute oral 
toxicity studies as per revised OECD Organization of 
Economic Co-operation and Development guidelines 
(OECD No. 425). The C. gigantea white flower extracts 
were devoid of any toxicity up to 2000 mg/kg body 
weight in albino rats (200-220g) of either sex for a 
single oral dose monitored for 12 days. The optimum 
conditions for experiments were decided on the basis of 
pilot experiments carried out using three animals per 
group. For further experiments, a group of at least six 
animals was used for individual treatment. Based on 
exploratory studies, antidiabetic activity was 
investigated using the methanol, chloroform, and ethyl 
acetate extracts respectively. The control group received 
only the vehicle. The groups were observed mortality 
and behavioral changes during 48 h. 
Evaluation of anti-diabetic activity  
Before starting the experiment, animals were separated 
according to their body weight. The animals were 
injected intraperitoneally with freshly prepared alloxan 
monohydrate at a concentration of 100 mg/kg in normal 
saline solution (0.9 w/v% NaCl), appears to be the 
easiest, most reliable practical method of inducing 
diabetes mellitus. A volume equivalent to 1 ml of the 
stock solution was given intraperitoneally after which 
Manivannan and Shopna                                                                                Journal of Drug Delivery & Therapeutics. 2017; 7(3):106-111                                     
ISSN: 2250-1177                                                                       [108]                                                                      CODEN (USA): JDDTAO 
the blood glucose levels were measured at regular 
intervals (i.e., every 6 h) four times daily for three days 
using digital display glucometer (One touch - Johnson & 
Johnson Ltd.). Alloxan administration resulted in 
significant elevation of glucose level and reduction in 
body weight. Diabetes was confirmed by the elevated 
blood glucose levels determined at 72 h. Initial blood 
sample was taken before the oral administration of the 
standard drug glibenclamide, test extracts at a dose of  
300 mg/kg of C. gigantea white. The blood glucose 
level test was done on the normal, diabetic, and treated 
diabetic rats were measured at 0, 4, 8 and 12 days after 
oral administration of glibenclamide and plant extracts. 
Biochemical analysis 
After blood glucose estimation on day 12, whole blood 
samples were drawn from the tail vein during the course 
of the experiment. At the end of the experimental period 
(12 days), the rats were anesthetized with chloroform 
following a 12 - hour fast. Blood samples were drawn 
by cardiac puncture into plain tubes.  The blood samples 
were centrifuged at 3500 rpm for 20 minutes using a 
refrigerated centrifuge at 4°C (Remi Laboratory 
Instruments, Mumbai, India). The serum collected was 
stored at -20°C until needed. Serum albumin was 
determined using the bromocresol (BCG) green method 
with an Autopak kit. The total protein present in serum 
was estimated by the Biuret method
9
 using an Autopak 
kit. Serum was separated and analyzed for serum 
cholesterol,
10
 serum HDL,
11
 serum LDL,
12 
serum 
creatinine,
13
 serum urea,
14
 levels of hemoglobin using 
the ion exchange resin method
15
 with kits purchased 
from Diotek India Ltd, Mumbai, India, were estimated. 
To the animals, standard drug glibenclamide tablets (10 
mg / kg orally) and the test extracts (250 & 500 mg / kg 
orally) were administered by dissolving in 2% Tween - 
80 / distilled water and normal saline respectively.  
Statistical analysis 
All the values of body weight, fasting blood sugar, and 
biochemical estimations were expressed as mean ± 
standard error of mean (SEM) and analyzed for 
ANOVA and post hoc Dunnet’s t-test. Differences 
between groups were considered significant at P < 0.05 
levels. 
RESULTS AND DISCUSSION 
Alloxan induced anti diabetic activity  
The anti-diabetic effect of the test extracts on the blood 
glucose levels of diabetic rats is shown in Table 1. The 
effect seems to reach the maximum after the 12
th
 day of 
treatment and remains constant. Glibenclamide used as 
standard drug exhibited the highest activity with a final 
decrease of 87.26 ± 2.68 mg on day 12, followed by 
ethyl acetate extract at dose of 250 & 500 mg / kg 
(124.41 ± 2.56 and 104.41 ± 2.69 mg) and  chloroform 
extract at a dose of 250 & 500 mg / kg (131.25 ± 2.64 
and 109.25 ± 2.67 mg) respectively. There is no 
significant change in the blood glucose levels of rats in 
group I that received normal saline solutions (negative 
control). Table 2 showed the body weight changes in the 
normal and experimental animals in each group. The 
mean body weight of the animals after 12 days of 
treatment with chloroform and ethyl acetate extract (500 
mg / kg) and glibenclamide (10 mg/kg) was 179.29 ± 
4.38, 186.82 ± 4.34, and 198.32 ± 4.33 mg/kg 
respectively.
 
Table 1: Effect of extracts from Calotropis gigantea white on fasting blood glucose level in alloxan induced diabetic rats 
Group Treatment Fasting blood glucose level (mg/dI) 
Initial    4
th
 day   8
th
 day 12
th
 day 
I 
 
Normal Control 85.42 ± 2.64    86.83 ± 1.12    84.00 ± 1.16      85.68 ± 1.40 
II Diabetic Control 195.72 ± 4.24   
 
214.12 ± 4.26   
 
236.22 ± 2.39    
 
258.16 ± 2.52 
III (Glibenclamide 10 mg/kg) 196.36 ± 2.52   
 
158.16 ± 2.43    
 
125.26 ± 2.81    
 
87.26 ± 2.68 
IV Chloroform extract (250 mg/kg) 198.57 ± 2.83   
 
174.45 ± 2.47    
 
158.84 ± 2.37    
 
131.25 ± 2.64
 
V Chloroform extract (500 mg/kg) 198.57 ± 2.83   
 
167.45 ± 2.47    
 
145.54 ± 2.37    
 
109.25 ± 2.67
 
VI Ethyl acetate extract (250 mg/kg) 194.62 ± 2.66    
 
168.36 ± 2.29    
 
149.27 ± 2.62    
 
124.41 ± 2.56 
VII Ethyl acetate extract (300 mg/kg) 196.39 ± 2.56    
 
159.25 ± 3.45    
 
137.26 ± 3.56    
 
101.41 ± 2.69 
Values are expressed in Mean ± SD (n=6).      There is no significant difference between standard and test drug at P< 0.05 significant level. 
 
Table 2: Effect of extracts from Calotropis gigantea white on body weight in alloxan induced diabetic rats 
Group Treatment Body weight of the animal (g) 
Initial 4
th
 day 8
th
 day 12
th
 day 
I Normal Control 212.67 ± 1.33 207.33 ± 4.52 210.28 ± 2.13
 
211.17 ± 3.15
 
II Diabetic Control 203.22 ± 1.32 192.67 ± 2.84 167.43 ± 2.36
 
121.33 ± 3.16
 
III Glibenclamide (10 mg/kg) 218.42 ± 2.44 207.46 ± 4.38
 
204.29 ± 3.44
 
198.32 ± 4.33
 
IV Chloroform extract (250 mg/kg) 219.36 ± 1.67 194.30 ± 4.24 172.38 ± 3.26
 
165.17 ± 4.36
 
V Chloroform extract (500 mg/kg) 216.98 ± 2.41 209.61 ± 4.34 186.48 ± 3.42
 
179.29 ± 4.38
 
VI Ethyl acetate extract (250 mg/kg) 217.37 ± 2.29 199.33 ± 4.26 178.63 ± 3.32
 
168.82 ± 4.39
 
VI Ethyl acetate extract (500 mg/kg) 217.37 ± 2.29 199.33 ± 4.28 188.63 ± 3.42
 
186.82 ± 4.34
 
Values are expressed in Mean ± SD (n=6).         There is no significant difference between standard and test drug at P< 0.05 significant level. 
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Table 3: Effect of extracts from Calotropis gigantea white on 12
th
 day on biochemical parameters in alloxan induced 
diabetic rats (mg/dI) 
Groups Treatments  
Biochemical parameter 
Hemoglobin Albumin Serum Urea Serum 
Creatinine 
I Normal Control 13.25 ± 0.32 3.64 ± 0.17 25.52 ± 1.2 0.64 ± 0.2 
II Diabetic Control 9.56 ± 0.47 2.47 ± 0.15 56.43 ± 1.7 0.98 ± 0.5 
III Glibenclamide (10 mg/kg) 12.91 ± 0.48 3.82 ± 0.14 32.14 ± 2.4 0.56 ± 0.2 
IV Chloroform extract (250 mg/kg) 11.12 ± 0.42 3.72 ± 0.15 43.32 ± 2.1 0.73 ± 0.4 
V Chloroform extract (500 mg/kg) 12.26 ± 0.46 3.55 ± 0.17 38.32 ± 2.3 0.62 ± 0.4 
VI Ethyl acetate extract (250 mg/kg) 11.39 ± 0.44 3.49 ± 0.14 41.21 ± 1.8 0.78 ± 0.5 
VII Ethyl acetate extract (500 mg/kg) 12.69 ± 0.48 3.78 ± 0.16 34.41 ± 2.2 0.58 ± 0.2 
Values are expressed in Mean ± SD (n=6).    There is no significant difference between standard and test drug at P< 0.05 significant level. 
 
Table 4: Effect of extracts from Calotropis gigantea white on 12
th
 day on biochemical parameters in alloxan induced 
diabetic rats (mg/dI) 
Groups Treatments Biochemical parameter 
Serum 
Protein 
Serum 
Cholesterol 
Serum HDL Serum LDL 
I Normal Control 7.38 ± 0.45 158.12 ± 3.5 38.22 ± 1.7 84.33 ± 3.4 
II Diabetic Control 4.36 ± 0.23 247.23 ± 5.2 28.38 ± 1.5 187.49 ± 6.8 
III Glibenclamide (10 mg/kg) 6.98 ± 0.84 138.46 ± 4.2 48.43 ± 1.7 69.62 ± 4.4 
IV Chloroform extract (250 mg/kg) 6.45 ± 0.82 165.24 ± 5.2 30.32 ± 1.5 115.10 ± 5.2 
V Chloroform extract (500 mg/kg) 6.84 ± 0.84 149.23 ± 4.4 36.10 ± 1.8 78.70 ± 4.5 
VI Ethyl acetate extract (250 mg/kg) 6.38 ± 0.82 162.24 ± 5.8 33.63 ± 1.4 109.45 ± 5.1 
VII Ethyl acetate extract (500 mg/kg) 6.89 ± 0.85 144.12 ± 4.3 44.28 ± 1.8 73.70 ± 4.6 
Values are expressed in Mean ± SD (n=6).   There is no significant difference between standard and test drug at P< 0.05 significant level. 
 
Biochemical analysis  
The biochemical parameters (Table 3 & 4) such as 
serum cholesterol, serum LDL, serum urea and serum 
creatinine levels were significantly decreased and HDL 
levels were increased by test various extracts of C. 
gigantea white and glibenclamide. The results also 
showed the levels of hemoglobin in control and 
experimental groups of rats. A significant decrease in 
the level of hemoglobin was observed in diabetic rats 
(9.56 ± 0.47) when compared to control rats. After 
treatment with glibenclamide (10 mg/kg) and 
chloroform and ethyl acetate extracts of C. gigantea 
white (250 & 500 mg/kg) to diabetic rats resulted (12.91 
± 0.48 and 12.26 ± 0.46, 12.69 ± 0.48 mg) in the 
restoration of hemoglobin level to near normal (P<0.05). 
Serum urea and serum creatinine levels were decreased 
significantly (p<0.05) after the treatment with 500 mg of 
chloroform, ethyl acetate extracts and glibenclamide 
(urea: 38.32 ± 2.3; 34.41 ± 2.2; and 32.14 ± 2.4 mg; 
creatinine: 0.62 ± 0.4; 0.58 ± 0.2; and 0.56 ± 0.2 mg) 
and the activity was comparable with that of the 
standard drug glibenclamide (urea: 32.14 ± 2.4; 
creatinine: 0.56 ± 0.2 mg) respectively. 
The present investigation showed the level of lipids in 
normal and tested animals. Administration of the 
chloroform and ethyl acetate extracts of the flowers of 
C. gigantea to alloxan monohydrate -diabetic rats 
protected the alterations of lipid levels. There was a 
significant increase in total protein content in the treated 
diabetic rats compared with the diabetic controls. The 
mean total protein content in rats treated with the test 
chloroform and  ethyl acetate extract at a dose of 500 
mg / kg was 6.84 ± 0.84, 6.89 ± 0.85 respectively, which 
were slightly lower than that the total protein content in 
rats treated with the glibenclamide at dose of 10 mg / kg 
(6.98 ± 0.84 mg). There was a significant decrease in the 
levels of total cholesterol (149.23 ± 4.4; 144.12 ± 4.3 
mg) and significant increase in the level of HDL-
cholesterol (36.10 ± 1.8; 44.28 ± 1.8 mg) and LDL- 
cholesterol (78.70 ± 4.5; 73.70 ± 4.6 mg) respectively 
and the activity was comparable with that of the 
standard drug, glibenclamide (total cholesterol: 138.46 ± 
4.2 mg; HDL; 48.43 ± 1.7 mg; LDL: 69.62 ± 4.4 mg). 
From the results, it is revealed that the test chloroform, 
and ethyl acetate extracts at a dose level 250 & 500 mg / 
kg, showed a significant reduction in blood sugar level 
day in a progressive manner comparable to 
glibenclamide. The treatment of diabetes with 
phytomedicine proved much safer than synthetic drugs 
throughout the world and gained importance in recent 
years
16
. The mean body weight of the diabetic rats 
decreased significantly (P < 0.05) compared to diabetic 
treated rats. The administration of a various extract of C. 
gigantea white restored these levels significantly 
towards normal. This may also be due to the protective 
effect of the extracts in controlling muscle wasting i.e. 
reversal of gluconeogenesis. Due to insulin deficiency 
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protein content is decreased in muscular tissue by 
proteolysis
17
. Alloxan caused body weight reduction, 
which is reversed by chloroform and ethyl acetate 
extract at high dose (500 mg/kg) is more effectively than 
at low dose (250 mg/kg) after 12 days of treatment.  
Biochemical parameters indicate that flower extracts of 
this plant had favorable effects on lipid metabolism of 
diabetic rats. An increase in the level of hemoglobin in 
the diabetic control group of rats is due to the presence 
of a large amount of blood glucose which reacts with 
hemoglobin to form glycosylated hemoglobin
18
. 
Administration of alloxan decreases serum albumin 
levels due to increased non-enzymatic glycosylation of 
protein
19
. Treatment of diabetic rats with chloroform and 
ethyl acetate extracts restored albumin to normal levels. 
On administering at 250 and 500 mg / kg various test 
extracts from C. gigantea white orally to diabetic rats 
decreased serum urea and creatinine, more effectively, 
and could be explained by the regenerative ability of the 
renal function. Diabetic produces the elevation of urea 
and creatinine which are considered to be significant 
markers of renal dysfunction
20
. The diabetic effect of 
plant extracts was similar to that of glibenclamide and 
appears to be through inhibition of gluconeogenesis 
since serum urea was reduced and skeletal muscle mass 
was increased. The elevated level of serum cholesterol, 
LDL, and reduced level of HDL possess to be rise of a 
factor for developing microvascular complication 
leading atherosclerosis and cardiovascular diseases like 
coronary heart disease
21
. 
The results of the present study are also supported by 
the earlier reports on the hypoglycemic activity of C. 
gigantea leaves and flowers (purple color) extract
22
, 
against alloxan induced diabetes mellitus. In this study, 
the maximum activity was found in chloroform and 
ethyl acetate extracts of C. gigantea white flowers have 
been reported to contain 4-methoxy-3-(methoxymethyl) 
phenol and 4-methoxy-N2-(5–bromo-2-methoxy 
benzylideno) benzhydrazide is the major compounds in 
the both extracts from GC-MS spectrum reported 
previously
23
. Phenolic compounds were considered as 
the main contributors responsible for the free radical 
scavenging activity) of the total hexane extract of many 
plants
24
 attributed the anti-diabetic, anti-inflammatory 
anti-tumor and anti-proliferative effect of many Labiatae 
species. Alkaloids, glycosides, carbohydrate, bitter 
principles, and saponins have similarly been implicated 
in the antidiabetic activities of a plant
25
. Alloxan 
destroys insulin-producing pancreatic ß-cells through 
the formation of reactive oxygen species that cause 
tissue damage
26
. However, it seems reasonable to 
suggest that the antioxidant and radical scavenging 
effects of this plant
23
 may play a key role in protecting 
pancreatic tissues from oxidants including that 
generated by alloxan. However, the presence of these 
compounds in C. gigantea extracts could be mediated, at 
least in part, through activation of these natural products 
in the in the diabetes treatment have decreased blood 
glucose levels of diabetic rat and protected the 
alterations of lipid levels.  
CONCLUSION 
Our study clearly showed that Calotropis gigantea white 
caused marked hypoglycemic activity in alloxan-
induced diabetic rat model which indicates antidiabetic 
potentials of the chloroform and ethyl acetate; extracts 
have beneficial effects on blood glucose levels. Our 
results support overall in vivo antidiabetic activity of the 
extracts that may prove to be of clinical importance in 
improving the management of diabetes. In addition, 
biochemical investigations have clearly elucidated the 
mechanism of action and will be helpful this plant 
extracts as a therapeutic target in diabetes research and 
the establishment of the exact mechanism(s) of action. 
The toxic effects and pharmacological activities of these 
plants should also be elucidated.  
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